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Abstract
Background: The Y-chromosome (Yc) and testosterone (T) increase blood pressure and may
also influence renal electrolyte excretion. Therefore, the goal of this study was to determine if the
Yc combined with T manipulation could influence renal Na and K excretion.
Methods: To investigate the role of the Yc and T, consomic borderline hypertensive (SHR/y) and
normotensive Wistar-Kyoto (WKY) rat strains were used (15 weeks) in three T treatment groups:
castrate, castrate with T implant and gonadally intact males. Urine was collected (24 hrs at 15
weeks of age) for Na and K measurements by flame photometry. RT-PCR was used to demonstrate
the presence of renal androgen receptor (AR) transcripts. Plasma T and aldosterone were
measured by RIA. In another experiment the androgen receptor was blocked using flutamide in the
diet.
Results: Na and K excretion were decreased by T in SHR/y and WKY. AR transcripts were
identified in SHR/y and WKY kidneys. Plasma aldosterone was decreased in the presence of T.
Blockade of the AR resulted in a significant increase in Na excretion but not in K excretion in both
SHR/y and WKY males.
Conclusion:  T influences electrolyte excretion through an androgen receptor dependent
mechanism. There was not a differential Yc involvement in electrolyte excretion between WKY
and SHR/y males.
Background
Human [1,2] and animal studies [3] have implicated Y-
chromosome (Yc) loci as influencing the onset of male
hypertension. In the Spontaneously Hypertensive Rat
strain (SHR), the SHR Yc contains a locus which increases
blood pressure (BP) approximately 20 mmHg compared
to the normotensive Wistar Kyoto (WKY) Y chromosome.
The Yc is only one genetic component of the total SHR
hypertension. In SHR males, the presences of testosterone
and androgen receptors through puberty are required for
development of the hypertension and associated sympa-
thetic nervous system potentiation, including the Yc com-
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ponent [4,5]. In examining phenotypes that mapped to
the Yc and differed between SHR and WKY, our laboratory
demonstrated an earlier rise of testosterone (T) levels in
SHR males leading into puberty [4] and this phenotype
mapped to the SHR Yc. Because of the unique biology of
the mammalian Yc the blood pressure phenotype and the
T timing phenotype cannot be separated using linkage.
With the interaction of T and the development of the Yc
hypertension, it is possible the two phenotypes are related
and a single genetic locus is responsible for both pheno-
types. In further support of a physiological T-SNS interac-
tion [6], we have previously reported that T increases the
storage and release of norepinephrine in isolated kidney
studies more in SHR, as compared to the WKY males [7].
Reckelhoff et al. [8] reported that in SHR, T increased renal
Na reabsorption, potentially through an androgen recep-
tor (AR) mediated mechanism in the kidney. These results
suggest a possible renal AR mediated response that may
influence one of the renal BP control mechanisms.
The renal system operates under a well auto-regulated
negative feedback system that maintains glomerular filtra-
tion rate and the filtered load of ions [9], as well as playing
an important role in long-term BP regulation. As part of
this regulation in genetic models of hypertension, the kid-
ney requires a high level of arterial pressure to excrete Na
and water [10] and the increase in renal arterial perfusion
pressure results in increased excretion of water and Na.
Fluctuations in BP and ion concentration can initiate
renal and cardiovascular compensatory mechanisms
through the renin angiotensin system, and aldosterone
secretion [11]. Other studies comparing urinary Na excre-
tion of SHR and WKY males [12,13] have found decreased
urinary Na excretion and a reduced renal ability to excrete
Na, in spite of BP differences. Therefore, the hypothesis to
be tested was that testosterone and the hypertensive Yc
would increase renal sodium reabsorption.
Methods
The following 3 studies ask the questions: Study 1-Does
testosterone influence urinary sodium and potassium
excretion, as well as, systolic BP?; Study 2-Will blocking
the androgen receptor mimic the effects of castration on
electrolyte excretion?; Study 3-Is there evidence for AR
transcripts in the kidney?
Design
Study 1 utilized a two strain by three treatment design,
using SHR/y and WKY males 8 weeks of age. The treat-
ments consisted of gonadally intact controls (control, n =
8/strain), castrates (cast, n = 6/strain), and castrates with
testosterone implants (cast+Ti, n = 6/strain). Also 4 age
matched females of each strain were tested for 24 hr uri-
nary Na as a comparison to males. Study 2 used two
strains-WKY(n = 6) and SHR/y(n = 6), and two treat-
ments-starting with the control period followed by 4 wks
of dietary flutamide administration (83 mg/kg body
weight; Sigma Chemical Co., St. Louis, MO) in the same
animals. Study 3 used kidneys collected from 3 adult
males each from two strains (WKY, SHR/y).
Animal Models
The Y-chromosome (Yc) animal model used in this study
consisted of the consomic borderline hypertensive (SHR/
y), and normotensive Wistar-Kyoto (WKY) rats [14]. SHR
and WKY rats were originally obtained from Harlan
Sprague-Dawley (Indianapolis, IN) in 1981 (SHR/hsd
and WKY/hsd), and colonies have been maintained at the
University of Akron research facility. To develop the SHR/
y consomic strain, an SHR male was crossed with a WKY
female. A male offspring was then crossed to a WKY
female and then a son of this cross was crossed to a WKY
female. These crosses have been repeated for over 20 gen-
erations, creating the strain designated SHR/y. The
repeated crosses have replaced the autosomal and X-
linked loci of the parental SHR with the alleles of the
maternal WKY strain, while the SHR Y chromosome
remains. Therefore, the SHR/y male has an SHR Yc, with
the autosomes and an X-chromosome from the WKY
female. In comparison, the WKY male has a WKY Yc, with
the autosomes and an X-chromosome from the WKY.
Comparisons between WKY and SHR/y males allow us to
investigate the role of the SHR Yc in a WKY genetic back-
ground and any genetic differences between strains must
map to the Y chromosomes. For a detailed review, see Ely
et al. [15]. All animals were treated in a humane manner
according to NIH guidelines, and the University of Akron
Institutional Animal Care and Use Committee (IACUC)
approved all experiments.
Housing
Animals were housed in pairs according to their strain and
maintained in polycarbonate cages (48 cm × 27 cm × 20
cm) with stainless steel covers and heat-treated bedding
(R.J. Murphy hardwood Sani Chips). Rats were subjected
to a 12 h/12 h light/dark cycle and maintained on a nor-
mal sodium diet (0.3% Na, Prolab 3000 Rat/chow 3000,
PMI Feeds, St. Louis, MS). Food and water was accessible
ad libitum. The amount of Na in the food was 0.3% and
previous studies have not shown that testosterone treat-
ment increases Na intake.
Testosterone Experiments
Male rats to be castrated were initially 8 weeks old,
sedated with Sodium Brevital (50 mg/kg, IP; E. Lilly, Indi-
anapolis, IN), and both testes were removed. In a similar
manner, male rats to be implanted (8 weeks old) were cas-
trated, shaved along the base of the neck, and an incision
0.5 cm long was made. The T implant was inserted
beneath the skin parallel to the longitudinal axis of theBMC Physiology 2008, 8:5 http://www.biomedcentral.com/1472-6793/8/5
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rat. Briefly testosterone implants [6,7] for castrated rats at
8 weeks of age were prepared by cutting single lumen clear
50 Silastic tubing (0.062" ID × 0.125" OD) into strips that
measured 16 mm in length with 12 mm of the tube
packed with testosterone propionate (Sigma Chemical
Co., St. Louis, MO. Each implant was replaced every two
weeks for duration of the experiment [5].
Testosterone and Aldosterone Assays
Animals were anesthetized at 15 weeks of age with
Sodium Brevital (50 mg/kg, IP; E. Lilly, Indianapolis, IN)
and a 2–3 ml retro-orbital blood sample was collected
between 1100 and 1700 hours and centrifuged for 5 min-
utes (5,000 ×G) to obtain plasma. Testosterone levels
were analyzed by RIA (Bio-Rad Laboratories, Hercules,
CA) [4]. The correlation with another kit was r = 0.991,
sensitivity was 0.08 ng/mL at the 95% confidence limit,
and the highest cross-reactivity with potential interfering
steroids was with dihydrotestosterone (6.65%). The coef-
ficient of variation for our sample intra-run was 7.4% to
11.6% and for inter-run was 12.5% to 16.96%.
Aldosterone levels were analyzed in plasma by RIA (Diag-
nostic Systems Laboratories, Inc. Webster, Texas). Sensi-
tivity was 7.64 pg/mL. The highest cross-reactivity with
potential interfering steroids was with corticosterone
(0.02%). The coefficient of variation for our sample intra-
run was 3.3% to 4.5% and for inter-run was 5.9% to 9.8%.
Electrolyte Measurement
Plasma was collected for sodium levels in control and cas-
trated animals of each strain at 15 weeks of age using pen-
tothal anesthetic (50 mg/kg, i.p). Urine was collected for
24 hours at 16 weeks of age in order that the volume was
not affected by the blood collection at 15 weeks, while the
animals were housed in metabolic cages and maintained
on their food and water. One ml of mineral oil was placed
into each urine-collecting cup prior to the collection
period to prevent evaporation of the urine. Sodium and
potassium concentrations were measured by flame pho-
tometry (Coleman model 51; Bacharach, Inc., Pittsburgh,
PA).
Systolic Blood Pressure
Weekly systolic blood pressure for each strain and treat-
ment group was monitored for the duration of the study.
Blood pressure was measured via tail sphygmomanome-
try and recorded on a physiograph (Desk Model Type
DMP 4A, E& M Instruments Co., Inc., Houston, TX)
between 1100 and 1400 hrs. The animals were placed into
a warming chamber for 20 minutes at 38°C to dilate tail
arteries, transferred to a restraint, and a tail cuff was
slipped around the base of the tail. Pressures were then
determined from the average of 5 systolic blood pressure
recordings, which took 2–3 min [3,14].
Study 3: Is There Evidence for Androgen Receptors in the 
Kidney?
The objective of this experiment was to determine if
androgen receptor (AR) transcripts were present in the
kidney of SHR, SHR/y and WKY males. Spontaneously
hypertensive rats (SHR) were used to see if WKY and SHR/
y rats were similar in AR presence. Gonadally intact males
at 15 weeks of age (n = 3/group) from our stock colonies,
as previously described, were used to study the presence of
AR transcripts in each strain. Animals were anesthetized
with pentothal (50 mg/kg, ip) and kidneys removed and
placed on foil on dry ice. All animals were housed in a
similar manner to study 1.
Androgen Receptor RT-PCR
Total cellular RNA was isolated from frozen kidneys from
SHR, SHR/y and WKY males with RNA STAT-60 (TEL-
TEST, Friendswood, TX). For cDNA production the RNA
was DNased (Ambion, Austin, TX) with 2 µg used as a
template with avian reverse transcriptase (Enhanced
Avian HS RT, Sigma Chemical Co., St.Louis, MS), 10×
Buffer, dNTPmix, a mix of random nonamers (Sigma
Chemical Co., St. Louis, MS), and water to a total volume
of 20 µl. RNase inhibitor (SUPER-In, Ambion, Austin, TX)
was included to insure RNA integrity. A RT control minus
the RT enzyme was included for each sample. The cDNA
was amplified at 94°C for 4 min.; 35 cycles of 94°C for 1
min., 52°C for 1 min., 72°C for 1 min.; 72°C for 7 min.
Primers were designed from Genbank sequence J05454
for the rat AR receptor gene cDNA. Primer sequences con-
sisted of the reverse primer, DK2 5'TGCTGCCTTCGGA-
TATTACC and the forward primer DK3 5'
TAGGGCTGGGAAGGGTCTAC. A positive control (cDNA
from testis) and negative control (no template) were
included in each set of PCR reactions. PCR products were
visually observed on 1% agarose gels and bands of 580 bp
were identified as the androgen receptor transcript.
Statistics
Data were analyzed and graphed with Sigma Statistical
Software (Sigma Stat and Sigma Plot, Jandel Scientific
Software, San Rafael, CA). Two-way ANOVA using fluta-
mide or T treatment and strain as factors were used to ana-
lyze plasma T and aldosterone, urinary electrolytes, and
kidney weight related variables with appropriate follow
up t-tests (Tukey's or Neuman-Keuls). Significance was
assumed with a p < 0.05.
Results
Urine Electrolyte Analysis
Figure 1 shows urinary sodium (Na) concentration
(mmol/hr/100 g body weight), from study 1, at 15 weeks
for each strain and treatment. In both SHR/y and WKY
strains, the castrate groups excreted more Na than the con-
trol groups and T restored Na excretion toward that ofBMC Physiology 2008, 8:5 http://www.biomedcentral.com/1472-6793/8/5
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control values (two-way ANOVA: T treatment (F = 10.9, p
< 0.001), strain (F = 13.5, p = <0.001), and T treatment x
strain interaction (F = 3.3, p = 0.02). There were no signif-
icant Na excretion differences between SHR/y and WKY
strains for controls or each T treatment. In order to com-
pare for a gender difference in Na excretion, the WKY
females excreted about 4× more Na than males: 0.0825 ±
0.014 vs. WKY males 0.024 ± 0.0017 mmol Na/hr/100 gm
body weight and similarly SHR/y females excreted about
4X more Na than SHR/y males: 0.0735 ± 0.0088 vs. 0.016
± 0.001 mmol Na/hr/100 gm body weight (p < 0.05 for
both strains).
Figure 2 shows urinary potassium (K) concentration
(mmol/hr/100 g body weight), from study 1, at 15 weeks
for each strain and treatment. In the SHR/y and WKY
strains, the castrate groups excreted more K than the con-
trol groups and T tended to restore K excretion toward that
of the control values (two-way ANOVA: T treatment F =
17.0, p < 0.001, strain F = 17.8, p < 0.001, and T treatment
x strain interaction F = 4.9, p = 0.002). There were no sig-
nificant K excretion strain differences.
Testosterone, Aldosterone, Blood Pressure and Kidney 
Weight
Table 1 shows serum testosterone (T) and BP at 15 weeks
for each strain and treatment. Testosterone levels were as
expected for each treatment with the control groups at
2.5–5.0 ng/ml, the castrate groups at less than 1 ng/ml,
and the castrate with T implant groups at 13–15 ng/ml.
The two-way ANOVA T results were: T treatment (F =
248.1, p < 0.001), strain (F = 1.4, p = 0.3), and T treatment
x strain interaction (F = 2.9, p < 0.05). There was a reduc-
tion in BP in both strains after castration and restoration
to control values with T addition. The two-way ANOVA
BP results were: T treatment (F = 6.2, p = 0.005), strain (F
= 8.1, p = 0.001), and T treatment x strain (F = 5.0, p =
0.003). Castration reduced kidney weight and T replace-
ment tended to restore it. The two-way ANOVA for T treat-
ment on relative kidney weight was significant (F = 99.1,
p < 0.001).
Figure 3 shows plasma aldosterone levels for SHR/y and
WKY gonadally intact control, castrate, and castrate with T
implant. In both strains castration increased plasma
aldosterone and T treatment restored it toward control
values. Two-way ANOVA for plasma aldosterone was sig-
nificant for T treatment (F = 15.6, p < 0.001, t-tests, *p <
0.05 compared to cast, *** = p < .001 compared to con-
trol). Figure 4 shows that plasma sodium levels were not
significantly altered by strain or treatment effects (2-way
ANOVA by strain and treatment).
Figure 5 shows the effect of androgen receptor blockade
on urinary Na and K excretion. There was a significant
increase in Na excretion in response to androgen receptor
blockade in both SHR/y (47%) and WKY (20%) strains. K
Urinary sodium (Na) concentration (mmol/hr/100 g body weight) for SHR/y and WKY gonadally intact (control, n = 8) males  castrate (cast, n = 6), castrate with T implant (cast+Ti, n = 6) at 15 weeks of age, expressed as means, ± SEM Figure 1
Urinary sodium (Na) concentration (mmol/hr/100 g body weight) for SHR/y and WKY gonadally intact (control, n = 8) males 
castrate (cast, n = 6), castrate with T implant (cast+Ti, n = 6) at 15 weeks of age, expressed as means, ± SEM.
*=p<.05 WKY cast vs. WKY Cast +Ti, **+p<.01 WKY Cast vs. WKY control, **=p<.01 SHR/y cast vs. SHR/y Cast +Ti, 
***=p<.001 SHR/y cast vs. SHR/y control.
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excretion showed a non significant trend for increase in
response to androgen blockade in both strains.
Androgen Receptor
The 580 bp amplified AR transcript is present in SHR (+
control), SHR/y and WKY males at 15 weeks of age (Figure
6). Since this method of analysis of RT-PCR is not quanti-
tative, no comparison can be made of levels of expression
between strains.
Discussion
Gender differences in electrolyte excretion have been
reported in rats and SHR females excrete more Na than
males [16,17]. It makes sense that females would excrete
more Na since in most mammals, females have a higher
Na intake than males [18]. This may be a protective mech-
anism to maintain blood volume in times of hemorrhagic
injury and during pregnancy, but in resting steady state
situations, the Na would need to be excreted. There is evi-
dence that males have more physiological difficulty in
responding to blood loss than females [19,20]. Also there
Urinary potassium (K) concentration (mmol/hr/100 g body weight) for SHR/y and WKY gonadally intact control (control, n =  8) males, castrate (cast, n = 6), castrate with T implant (cast+Ti, n = 6) at 15 weeks of age, expressed as means, ± SEM Figure 2
Urinary potassium (K) concentration (mmol/hr/100 g body weight) for SHR/y and WKY gonadally intact control (control, n = 
8) males, castrate (cast, n = 6), castrate with T implant (cast+Ti, n = 6) at 15 weeks of age, expressed as means, ± SEM.
***=p<.001 SHR/y cast vs. SHR/control and SHR/y cast+Ti, ***=p<.001 WKY cast vs. WKY control, *=p<.05 WKY cast vs. 
WKY cast+Ti.
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Table 1: Serum Testosterone and Systolic Blood Pressure at 15 Weeks
Strain Treatment Serum Testosterone (ng/ml) Systolic Blood Pressure
 (SBP, mmHg)
Relative Kidney Weight 
(mg/100 g BW)
SHR/y control 5.6 +/-1.4 +++,&&&155.8+/-3.1 764+/-36.0
SHR/y cast 0.05+/-0.02 136.8+/-1.6 ###616+/-23.0
SHR/y cast +Ti +++14.84+/-0.51 142.2+/-2.4 $$916+/-19.0
WKY control 3.28+/-0.16 137.6+/-2.3 658+/-17.0
WKY cast 0.19+/-0.07 %126.0+/-4.6 636+/-24.0
WKY cast +Ti +++12.44+/-2.00 144.4+/-5.7 783+/-77.0
Serum testosterone (T) levels, systolic blood pressure and relative kidney weight at 15 weeks of age for SHR/y and WKY gonadally intact control 
(control), castrate (cast) and castrate with T implant (cast+Ti) males, expressed as means +/- SEM. The two-way ANOVA for serum T was 
significant for T treatment) F = 226.0, p < 0.001). Both T implant groups had elevated T compared to controls (+++ = p < .001). The two-way 
ANOVA for SBP was significant for T treatment (F = 8.1, p = 0.005), strain (F = 6.2, p = 0.001), and T treatment x strain (F = 4.9, p = 0.003). The 
two-way ANOVA for T treatment on relative combined kidney weight was significant (F = 99.1, p < 0.001). The SHR/y control group SBP was 
greater than the SHR/y cast+Ti (+++ = p < 0.01) and SHR/y cast group SBP (&&&= p < 0.001). The WKY cast group SBP was less than the WKY 
cast+Ti and control groups (% = p < 0.05). Relative combined kidney weight for SHR/y cast was significantly less than SHR/y control and SHR/y cast 
+Ti groups (### = p < 0.001). relative combined kidney weight for the SHR/y cast +Ti group was significantly greater than the SHR/y cast and 
control groups ($$ = p < 0.01).BMC Physiology 2008, 8:5 http://www.biomedcentral.com/1472-6793/8/5
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are reports of the presence of androgen receptors in
female kidneys of rats and mice [21,22]. In our studies,
the presence or absence of testosterone (T) altered renal
excretion of Na and K in the male borderline hypertensive
SHR/y and normotensive WKY strains. In addition, the
presence of the androgen receptor (AR) transcripts in the
kidney of each strain is consistent with the idea that T
binds to the AR in the kidney to play a role controlling Na
regulation. With regards to localization of the AR studies
have shown AR in proximal and distal tubules [23], and
Plasma aldosterone levels (pg/ml) for SHR/y and WKY gonadally intact control (control, n = 8), castrate (cast, n = 6), and cas- trate with T implant (cast+Ti, n = 6) expressed as means, ± SEM Figure 3
Plasma aldosterone levels (pg/ml) for SHR/y and WKY gonadally intact control (control, n = 8), castrate (cast, n = 6), and cas-
trate with T implant (cast+Ti, n = 6) expressed as means, ± SEM.
***=p<.001 WKY cast vs. WKY control,*=p<.05 WKY cast +Ti vs. WKY cast, *=p<.05 SHR/y cast +Ti vs. SHR/y cast, 
***=p<.001 SHR/y cast vs. SHR/y control.
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Plasma sodium (Na) levels by treatment group(n = 6/group, means, ± SEM, no significant differences, Two-way ANOVA strain  x treatment) Figure 4
Plasma sodium (Na) levels by treatment group(n = 6/group, means, ± SEM, no significant differences, Two-way ANOVA strain 
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in other locations within the kidney (pars recta and corti-
cal collecting duct (by real-time PCR) and low but detect-
able levels in medullary and cortical parts of the thick
ascending limb of Henle's loop [24].
Androgens could also be operating through the transcrip-
tional control of specific renal genes. Androgen regulated
genes in the kidney include several organic anion trans-
porters [23], which could be involved in the androgen
produced retention of electrolytes [24,25]. Indeed, Quin-
kler et al. showed that testosterone increased the expres-
sion of the alpha-subunit of the epithelial sodium
channel in a human renal proximal tubule cell line 2–3
fold which was blocked by flutamide [26]. This T effect on
renal function is not unique to males. Ovarectomized
females given T excreted less Na than ovarectomized
females [27], further supporting the notion that there may
be ARs present in the proximal tubules in both genders
[28]. To further support this data we found that SHR
females on a high Na diet with T implants excreted less Na
than intact females [27]. Plasma Na levels were constant
across treatments and cannot be used to explain urinary
Na differences. There are many regulatory mechanisms to
maintain plasma Na balance so it is not surprising that in
spite of Na intake or circulating hormone variations,
plasma Na remains constant. For instance, in a study from
our lab [5] we found that male, female and testicular fem-
inized males (mutant AR) had the same constant plasma
Na levels (145, 146,144 meq/L, respectively) in spite of
gender and AR differences.
Androgen receptor blockade produced a significant rise in
SHR/y and WKY male Na excretion suggesting a T depend-
ence on Na reabsorption in both strains similar to the
effects observed with castration. Flutamide has been used
as an anticancer drug and is classified as a nonsteroidal
antiandrogen. It competively blocks T at the AR forming
inactive complexes which cannot translocate to the
nucleus. The increased Na excretion was not as great with
flutamide as with castration, which may be due to some
ARs still functioning or possibly T working through non-
genomic AR mechanisms. Testosterone signaling through
non-genomic AR mechanisms has been described in rat
osteoblasts [29], AR free macrophages [30], and murine T
cells [31,32]; whereby T mediates only ligand-induced
Ca2+  import through non-voltage-gated Ca2+  channels
[31,32]. Recently, our lab has shown that T via the AR
influences Ca2+ signaling through an increase in Ca2+
mobilization in coronary artery adventitial fibroblasts
and consequently elevates collagen Type I production
[33]. In support of this finding Vicencio [34] has also
found that T induces Ca2+  increase by a nongenomic
mechanism in cultured rat cardiac myocytes.
The effect of androgen receptor blockade on urinary NA, K  in gonadally intact control (control) WKY and SHR/y males  and after flutamide (Flut) treatment (n = 6/group, * = p <  0.05, means, ± SEM) Figure 5
The effect of androgen receptor blockade on urinary NA, K 
in gonadally intact control (control) WKY and SHR/y males 
and after flutamide (Flut) treatment (n = 6/group, * = p < 
0.05, means, ± SEM).
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One percent agarose gel of RT-PCR androgen receptor (AR)  transcripts taken from SHR (for + control), SHR/y, and WKY  kidneys (n = 3/group) Figure 6
One percent agarose gel of RT-PCR androgen receptor (AR) 
transcripts taken from SHR (for + control), SHR/y, and WKY 
kidneys. The arrow indicates the 580bp amplified AR tran-
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ney (lane 3), no RT control (lane 4), SHR/y kidney (lane 5), 
no RT control (lane 6), ladder (lane 7), and no template con-
trol (lane 8).
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Further evidence that T is playing a role in Na reabsorp-
tion is provided by the aldosterone data. The removal of T
by castration produced a rise in plasma aldosterone and T
replacement lowered the aldosterone. This suggests that T
was acting to conserve renal Na and its removal caused
aldosterone to rise as a compensation. Again, there
appears to be a T threshold level for its influence on aldos-
terone levels since even when T increased 3–4x with
replacement the aldosterone levels did not suppress
below control values. Indeed, the same results were found
in male Sprague Dawley rats castrated and given T replace-
ment [35]. Based on in vitro data, T appeared to exert a
direct inhibitory effect on basal aldosterone release at the
level of adrenal zona glomerulosa cells, but there was no
effect on intracellular cAMP [35]. Further studies strongly
suggested that the specific inhibitory effect of T on aldos-
terone was through inhibition of aldosterone synthase
[35]. This is further supported by clinical observations in
hyperandrogenic women suggesting that circulating T
may inhibit adrenal 21- and/or 11B-hydroxylase activity
[36]. In our groups that were castrated and received T
replacement one might expect to observe greater Na reab-
sorption since T levels were 3–4x higher with replace-
ment, but the urinary Na levels were comparable to that
of the controls for each strain suggesting that there may be
a threshold level of T whereby further increases to not
affect Na retention mechanisms.
The renin angiotensin system (RAS) and specifically, angi-
otensinogen (AGT) has been shown to be modulated by
sex hormones [37]. Androgens can stimulate synthesis of
AGT in animal models [38] and this induction is tissue
specific. For instance, androgen has been reported to
increase kidney AGT mRNA levels, whereas it has only a
slight effect on liver AGT mRNA levels [39]. Androgens
may directly upregulate the proximal tubule renin-angi-
otensin system, increase the volume reabsorptive rate, and
thereby increase extracellular volume and blood pressure
and secondarily decrease serum angiotensin II levels [40].
We do not have tissue RAS measures, so it is not possible
to determine if the T effects are operating through a tissue
RAS system in the proximal tubules. Similarily, there is a
RAS-dopamine interaction that influences renal proximal
tubule cells [41]. Zeng et al. showed that AT1 and D1
receptors interacted differently in renal proximal tubule
cells from SHR and WKY [42]. Therefore, it is possible that
T can indirectly dopamine to produce renal electrolyte
effects. Further research is needed to clarify these RAS-cat-
echolamine interactions.
The same trend of decreased Na excretion in the presence
of T was observed with K excretion. K is passively trans-
ported across the cell membrane via one of several types
of channels in tubules [43]. This was surprising to us since
most often there is a reciprocal relationship between renal
Na/K exchange. Na and K, are largely exchanged via the
Na/K transporter. When the ratio of Na to K excreted was
compared, there were no differences between strains or
treatment groups. In the SHR/y and WKY strains, the
absence of T produced increased K excretion, and T
replacement normalized the effect. The AR blockade study
showed similar results except the K excretion with the AR
blocker was not as great as with castration. Most likely this
was due to not all of the ARs are functionally blocked with
the drug dosage used. Also relative kidney weight cannot
explain the excretion differences found with testosterone
manipulation, since the WKY strain did not have signifi-
cant kidney weight changes but did have excretion differ-
ences. The decrease in kidney weight in the SHR/y strain
that was castrated and its rescue in the castrates treated
with testosterone supports the findings of others who
have shown an anabolic effect of testosterone on kidney
weight [44-46].
Blood pressure cannot be used to explain the electrolyte
excretion differences with T manipulation since BP
decreased after castration and Na excretion increased. The
BP profile for each strain and treatment group is similar to
previously reported data from our lab [4,5,47] showing
decreased BP with castration and T treatment restored BP
to control or above control levels. In a Na balance study
comparing SHR and WKY males, Lundin et al. [12] did not
find increased SHR urinary Na excretion as expected due
to high BP, but instead a decreased urinary Na excretion
was found. Similar SHR urinary Na excretion results were
found by Osborn et al. [13] with a reduced renal ability to
excrete Na, in spite of increased blood pressure. Since T
was not measured in Osborn's studies, it is not known if
the reduced Na excretion may have been due to elevated T.
Conclusion
The excretion of Na and K in both SHR/y and WKY males
appear to be partially T dependent. In addition, the ele-
vated Na excretion in SHR/y and WKY following castra-
tion, further suggests that T can be an important player in
renal Na excretion. These differences in renal excretion of
Na and K cannot be solely and consistently explained by
changes in BP or anabolic effects on kidney weight. In
conclusion, the increased Na and K excretion following
castration, identification of renal AR transcripts, and loss
of Na with androgen blockade suggests that T is involved
in the regulation of Na balance.
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